Barrow, Hanley, Mewhinney & Strauss’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $46.1M | Buy |
|
|||||
|
2018
Q4 | $43.6M | Sell |
|
|||||
|
2018
Q3 | $62M | Buy |
|
|||||
|
2018
Q2 | $68.9M | Sell |
|
|||||
|
2018
Q1 | $48.5M | Sell |
|
|||||
|
2017
Q4 | $54.5M | Sell |
|
|||||
|
2017
Q3 | $83M | Sell |
|
|||||
|
2017
Q2 | $995M | Buy |
|
|||||
|
2017
Q1 | $955M | Sell |
|
|||||
|
2016
Q4 | $1.18B | Buy |
|
|||||
|
2016
Q3 | $1.22B | Buy |
|
|||||
|
2016
Q2 | $1.14B | Buy |
|
|||||
|
2016
Q1 | $498M | Sell |
|
|||||
|
2015
Q4 | $630M | Buy |
|
|||||
|
2015
Q3 | $538M | Sell |
|
|||||
|
2015
Q2 | $583M | Sell |
|
|||||
|
2015
Q1 | $635M | Sell |
|
|||||
|
2014
Q4 | $622M | Buy |
|
|||||
|
2014
Q3 | $557M | Sell |
|
|||||
|
2014
Q2 | $570M | Sell |
|
|||||
|
2014
Q1 | $705M | Buy |
|
|||||
|
2013
Q4 | $487M | Buy |
|
|||||
|
2013
Q3 | $255M | Buy |
|
|||||
|
2013
Q2 | $264M | Buy |
|